SCHEMBL11175176

SCHEMBL11175176

Cc1ccc(SC(=O)Nc2ccc(C3=NNC(=O)CC3C)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 16/20 0.66
▸ PDE3A Q14432 16/20 0.66
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ MAPT P10636 1/20 0.57
▸ KDM4E B2RXH2 2/20 0.54
▸ ALDH1A1 P00352 2/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ BLM P54132 1/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54
▸ TNNC1 P63316 1/20 0.52
▸ PDE4A P27815 2/20 0.46
▸ PDE4B Q07343 2/20 0.46
▸ PDE4C Q08493 2/20 0.46
▸ PDE4D Q08499 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11163401 0.90 PDE3B (0.65) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11162328 0.90 PDE3B (0.65) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11162969 0.90 PDE3B (0.67) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11171310 0.88 PDE3B (0.61) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11167091 0.87 PDE3B (0.60) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11165047 0.85 PDE3B (0.77) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11175054 0.84 PDE3B (0.62) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11173007 0.81 PDE3B (0.70) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11165225 0.81 PDE3B (0.70) PDE3BPDE3ASMN1; SMN2MAPTKDM4E
SCHEMBL11173120 0.81 PDE3B (0.70) PDE3BPDE3ASMN1; SMN2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4415571-A HYPOTENSIVE AGENTS; THROMBOSIS; ANTICOAGULANTS; CARDIOVASCULAR DISORDDERS BASF AKTIENGESELLSCHAFT (DE) 1983-11-15 — — US disclosed
EP-0042513-A1 Dihydropyridazinones, processes for their preparation and pharmaceutical compositions containing these compounds BASF Aktiengesellschaft (DE) 1981-12-30 — — EP disclosed
Send feedback